Acknowledgements Special thanks are due to Paola Murano from Nefrocenter Research Network, for her complimentary editorial assistance, and to Members of the AMD-OSDI Study Group on Injection Technique for critical reading and approval of the manuscript
Side Effects, Tolerability, and Who Should Start With Lower Doses Nausea, vomiting, and constipation occur in 2040% of patients starting GLP-1 therapy, primarily driven by gastric slowdown and altered gut motility
Read clinical review How does Mounjaro (tirzepatide) compare with liraglutide for weight loss and A1C reduction
Rutin protects against cyclophosphamide induced immunological stress by inhibiting TLR4-NF- B-mediated inflammation and activating the Nrf2-mediated antioxidant responses
Role of L-carnitine in the prevention of seminiferous tubules damage induced by gamma radiation: a light and electron microscopic study
GLP-1 medications are not recommended during pregnancy or breastfeeding, and some (like semaglutide) should be discontinued at least 2 months before a planned pregnancy
